Statins Inhibit Cytokines in a Dose-Dependent Response in Patients with Systemic Sclerosis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy
Link
http://link.springer.com/article/10.1007/s10753-018-0907-3/fulltext.html
Reference15 articles.
1. Baraut, J., L. Michel, F. Verrecchia, and D. Farge. 2010. Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis. Autoimmunity Reviews. 10 (2): 65–73. https://doi.org/10.1016/j.autrev.2010.08.003 .
2. Chizzolini, C., N.C. Brembilla, E. Montanari, and M.E. Truchetet. 2011. Fibrosis and immune dysregulation in systemic sclerosis. Autoimmunity Reviews. 10 (5): 276–281. https://doi.org/10.1016/j.autrev.2010.09.016 .
3. Trifari, S., C.D. Kaplan, E.H. Tran, N.K. Crellin, and H. Spits. 2009. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nature Immunology 10 (8): 864–871. https://doi.org/10.1038/ni.1770 .
4. Hwang SY, Kim JY, Kim KW, Park MK, Moon Y, Kim WU et al. IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB- and PI3-kinase/Akt-dependent pathways. Arthritis Research & Therapy. 2004;6(2):R120–R128. doi: https://doi.org/10.1186/ar1038 .
5. Murata, M., M. Fujimoto, T. Matsushita, Y. Hamaguchi, M. Hasegawa, K. Takehara, K. Komura, and S. Sato. 2008. Clinical association of serum interleukin-17 levels in systemic sclerosis: is systemic sclerosis a Th17 disease? Journal of Dermatological Science. 50 (3): 240–242. https://doi.org/10.1016/j.jdermsci.2008.01.001 .
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Association between statin use and the risk of gout in patients with hyperlipidemia: A population-based cohort study;Frontiers in Pharmacology;2023-02-15
2. Hearing Loss Secondary to Systemic Sclerosis Vasculopathy: Case Study with a Short Review;Clinical, Cosmetic and Investigational Dermatology;2022-05
3. Paraclinical Aspects in Systemic Sclerosis;International Journal of General Medicine;2022-04
4. Management of Endothelial Dysfunction in Systemic Sclerosis: Current and Developing Strategies;Frontiers in Medicine;2021-12-22
5. Lipid Alterations in Systemic Sclerosis;Frontiers in Molecular Biosciences;2021-12-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3